NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
Lab-grown meat: you may find it icky, but it could drive forward medical research 
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
A group of researchers is recently focused on coming up with a cure for skin cancer that developed from a severe skin disease called recessive dystrophic epidermolysis bullosa (RDEB). This medical progress is especially significant since children diagnosed with RDEB often develop life-threatening skin cancer as they grow old.
Epidermolysis bullosa is a genetic condition that causes a patient’s skin to become very vulnerable. A simple scratch can cause blisters on a patient’s skin. According to the Genetics Home Reference website, young adults who are diagnosed with this condition “have a very high risk of developing a form of skin cancer called squamous cell carcinoma.” The said cancer is often “unusually aggressive” and fatal.
The Clinical Cancer Research published the study this month (via Science Daily) confirming that scientists from Sidney Kimmel Cancer Center – Jefferson Health found a potential treatment for this type of cancer. The drug treatment will reportedly be tested in a clinical trial that will start this year.
SKCC’s Dr. Andrew South said in a statement that they are hoping the medication will become an effective cure for this type of cancer. "If we can reduce the cancer, or even reduce the spread of the cancer, that is going to improve patients' quality of life and extend their lifespan," Dr. South added.
The same report pointed out that the cancer squamous cell carcinoma can also be developed when someone has been extremely exposed to the sun. However, it can be averted easily, especially when diagnosed at an early stage. Unfortunately, this skin cancer can become quickly fatal for patients who have pre-existing conditions of epidermolysis bullosa.
On other related news, the work on developing a cancer cure has been non-stop for many scientists around the world. This could also be the reason why many experts were intrigued when a group of scientists from Israel announced in January that they could come up with a “complete cure” within a year. American Cancer Society's Dr. Leonard Lichtenfeld explained, “We hope that this approach also bears fruit and is successful. At the same time, we must always offer a note of caution that the process to get this treatment from mouse to man is not always a simple and uncomplicated journey.”
